Form 8-K - Current report:
SEC Accession No. 0001193125-26-270560
Filing Date
2026-06-15
Accepted
2026-06-15 11:31:39
Documents
19
Period of Report
2026-06-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rkda-20260611.htm   iXBRL 8-K 74067
2 EX-4.1 rkda-ex4_1.htm EX-4.1 156237
3 EX-4.2 rkda-ex4_2.htm EX-4.2 170257
4 EX-4.3 rkda-ex4_3.htm EX-4.3 167768
5 EX-4.4 rkda-ex4_4.htm EX-4.4 169780
6 EX-10.1 rkda-ex10_1.htm EX-10.1 379343
7 EX-10.2 rkda-ex10_2.htm EX-10.2 237502
8 EX-99.1 rkda-ex99_1.htm EX-99.1 16794
9 EX-99.2 rkda-ex99_2.htm EX-99.2 16055
10 GRAPHIC img192114479_0.jpg GRAPHIC 9353
11 GRAPHIC img193038000_0.jpg GRAPHIC 9353
  Complete submission text file 0001193125-26-270560.txt   1738062

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20260611.xsd EX-101.SCH 24852
22 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20260611_htm.xml XML 4672
Mailing Address 5956 SHERRY LANE SUITE 2000 DALLAS TX
Business Address 5956 SHERRY LANE SUITE 2000 DALLAS TX 214-974-8921
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 261089638
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)